Related references
Note: Only part of the references are listed.DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia
Brian Giacopelli et al.
GENOME RESEARCH (2021)
New strategies to treat AML: novel insights into AML survival pathways and combination therapies
Ramya Nair et al.
LEUKEMIA (2021)
How I treat acute myeloid leukemia in the era of new drugs
Courtney D. DiNardo et al.
BLOOD (2020)
Genome-wide analysis reveals the association between alternative splicing and DNA methylation across human solid tumors
Xiaohui Sun et al.
BMC MEDICAL GENOMICS (2020)
Acute Myeloid Leukemia, Version 3.2019
Martin S. Tallman et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7-H3
Xiao-wen Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Regulation of cancer immune escape: The roles of miRNAs in immune checkpoint proteins
Qin Yang et al.
CANCER LETTERS (2018)
Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma
Zhiliang Wang et al.
CANCER SCIENCE (2018)
Decreased SCIN expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia
Zhi-Hui Zhang et al.
MOLECULAR CARCINOGENESIS (2018)
The comprehensive molecular landscape of the immunologic co-stimulator B7 and TNFR ligand receptor families in colorectal cancer: immunotherapeutic implications with microsatellite instability
Jinghua Tang et al.
ONCOIMMUNOLOGY (2018)
Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer
Kentaro Inamura et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Clinical correlation of B7-H3 and B3GALT4 with the prognosis of colorectal cancer
Ting Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia
Bas J. Wouters et al.
BLOOD (2016)
Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
Elodie Picarda et al.
CLINICAL CANCER RESEARCH (2016)
Acute myeloid leukaemia
Asim Khwaja et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
B7-H3 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity
Wei Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells
Wei Zhang et al.
ONCOTARGETS AND THERAPY (2015)
Differential expression of 2IgB7-H3 and 4IgB7-H3 in cancer cell lines and glioma tissues
Zhenxin Wang et al.
ONCOLOGY LETTERS (2015)
B7-H3 protein expression in acute myeloid leukemia
Thomas Guery et al.
CANCER MEDICINE (2015)
Toward Individualized Therapy in Acute Myeloid Leukemia A Contemporary Review
Tapan M. Kadia et al.
JAMA ONCOLOGY (2015)
Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia
Yixin Hu et al.
Hematology (2015)
Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response
Cheng Chen et al.
EXPERIMENTAL CELL RESEARCH (2013)
B7-H3 overexpression in pancreatic cancer promotes tumor progression
Xin Zhao et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence
Tai-Wei Sun et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Acute Myeloid Leukemia Clinical Practice Guidelines in Oncology
Margaret R. O'Donnell et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Origination of New Immunological Functions in the Costimulatory Molecule B7-H3: The Role of Exon Duplication in Evolution of the Immune System
Jing Sun et al.
PLOS ONE (2011)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid Tumors
Hong Xu et al.
CANCER RESEARCH (2009)
4IgB7-H3 is the major isoform expressed on immunocytes as well as malignant cells
Y.-H. Zhou et al.
TISSUE ANTIGENS (2007)
Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains
P Steinberger et al.
JOURNAL OF IMMUNOLOGY (2004)
Characterization of mouse and human B7-H3 genes
MY Sun et al.
JOURNAL OF IMMUNOLOGY (2002)
B7-H3:: A costimulatory molecule for T cell activation and IFN-γ production
AI Chapoval et al.
NATURE IMMUNOLOGY (2001)
Share Paper
